Wave Life Sciences (WVE) Return on Capital Employed (2016 - 2025)
Historic Return on Capital Employed for Wave Life Sciences (WVE) over the last 11 years, with Q3 2025 value amounting to 0.84%.
- Wave Life Sciences' Return on Capital Employed rose 5000.0% to 0.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84%, marking a year-over-year increase of 5000.0%. This contributed to the annual value of 0.54% for FY2024, which is 22600.0% up from last year.
- According to the latest figures from Q3 2025, Wave Life Sciences' Return on Capital Employed is 0.84%, which was up 5000.0% from 0.78% recorded in Q2 2025.
- Wave Life Sciences' Return on Capital Employed's 5-year high stood at 0.45% during Q4 2024, with a 5-year trough of 2.09% in Q1 2023.
- Moreover, its 5-year median value for Return on Capital Employed was 0.91% (2021), whereas its average is 1.05%.
- Its Return on Capital Employed has fluctuated over the past 5 years, first plummeted by -11400bps in 2023, then skyrocketed by 12800bps in 2024.
- Wave Life Sciences' Return on Capital Employed (Quarter) stood at 0.91% in 2021, then crashed by -93bps to 1.76% in 2022, then increased by 24bps to 1.33% in 2023, then surged by 66bps to 0.45% in 2024, then plummeted by -87bps to 0.84% in 2025.
- Its Return on Capital Employed was 0.84% in Q3 2025, compared to 0.78% in Q2 2025 and 0.54% in Q1 2025.